0|10|Public
40|$|STATE OF UTAH Plaintiff and Appellee, v. JOHN LELEAE, Defendant <b>adn</b> Appellant Case <b>No.</b> 981189 -CA Priority No. 2 BRIEF OF APPELLEE APPEAL FROM A CONVICTION FOR AGGRAVATED ASSAULT, A SECOND DEGREE FELONY, IN VIOLATION OF UTAH CODE ANN. § 76 - 5 - 103 (1995), IN THE THIRD JUDICIAL DISTRICT COURT IN AND FOR SALT LAKE COUNTY, STATE OF UTAH, THE HONORABLE TYRONE E. MEDLEY, PRESIDING...|$|R
40|$|The Children Literature {{serves to}} prepare {{children}} for {{life with the}} themes it dealswith. Children try to dentify themselves with the characters, and onderstand the good and badsides of life in these works. Among these realities of life is there "Death", and it is aimed to tohelp them to comprehend this concept. Despite {{the fact that the}} child has difficulties inundeerstanding "Death" in the stories, he/she gradually starts to comprehend it <b>adn</b> feel <b>no</b> fearat the idea of death. In some works, wheras death is is portrayed as "eternal sleep", "ending oflife", sometimes "an award", and "non-existence",in some works, it is described as "the newbeginning of life", ascend to sky","liberation", and "Taking shelter beside "God". Under the lightof these explainations, since the child is informed well about the idea of "Death", and the childsees it as the partb of reality of life. Consequently, these works aim to make life more meaningfulinspite of the all difficulties of life...|$|R
30|$|Conventionally, {{power is}} {{supplied}} to electrical customers via large central power plants through transmission and distribution networks. With distributed energy resources (DERs) accessing it in high density, the distribution network transforms from passive to active with bi-directional flow. According {{to the definition of}} CIGRE [1], an active distribution network (ADN) utilizes DERs and flexible grid topology to manage power flows. It has been estimated that 80 % of the supply interruptions faced by customers are because of failures that occur in the distribution network. In an <b>ADN,</b> the loads <b>no</b> longer have only a single power supply path because of the introduction of DERs, such as distributed generation (DG), batteries (BEs), and plugged-in electric vehicles (EVs). The increasing penetration levels of DERs together with suitable control strategies are making it possible for an ADN to meet higher reliability requirements and improve power supply security [2, 3, 4]. When the network undergoes some disturbance, one promising strategy is to operate some portions of the ADN in island mode to ensure uninterrupted power supplies for some of the significant loads [5, 6, 7]. In this situation, the island partition and the power dispatch method within islands are the most important variables for maximizing the benefits of the available DERs.|$|R
40|$|Dissertação de Mestrado Integrado em Medicina VeterináriaO Carcinoma Espinocelular (CEC) é uma {{neoplasia}} com origem nos queratinócitos e representa aproximadamente 5 % das neoplasias cutâneas em cães. A variante cutânea do CEC apresenta-se preferencialmente em áreas de pele despigmentada com pouco pelo e acomete animais de ambos os sexos, com idade compreendida entre os 6 e os 10 anos. É uma neoplasia localmente invasiva, mas a ocorrência de metástases é pouco frequente. Vários factores etiológicos parecem dar origem ao CEC cutâneo. No entanto, a radiação ultravioleta (UV) e o papilomavírus (PV) são os mais frequentes. O aumento da altitude, diminuição da latitude (países tropicais) e depleção da camada do ozono aumentam a quantidade de raios UV que atingem a superfície terrestre. As lesões cutâneas causadas pela radiação UV iniciam-se com dermatite, progridem para queratose actínica (lesão pré-neoplásica) e esta pode evoluir para CEC. A radiação UV exerce efeito no gene supressor de tumores p 53, levando à sua mutação. A lesão mais frequentemente causada pela radiação solar nas células da epiderme é a formação de dímeros de timina entre as bases pirimidínicas do <b>ADN.</b> <b>No</b> que diz respeito ao PV, quatro dos sete tipos deste vírus descritos em cães foram associados à transformação maligna para CEC. São eles: o Papilomavírus oral canino (PVOC), Canis familiaris Papilomavírus tipo 2 (CfPV 2), Papilomavírus canino tipo 3 (PVC 3) e o Papilomavírus canino tipo 4 (PVC 4). Pensa-se que o PV actua como cofator de lesões provocadas por radiação solar, bloqueando a apoptose de células lesadas por raios UV. O PV pode também causar mutação direta em p 53 ao inativá-lo. As lesões de CEC cutâneo podem manifestar-se de forma proliferativa ou de forma erosiva. O diagnóstico presuntivo é feito com base na anamnese e exame físico, mas o exame histopatológico após biópsia é essencial para chegar a um diagnóstico definitivo. A excisão cirúrgica com amplas margens é a terapêutica que obtem melhores resultados a longo prazo. A cirurgia combinada com radioterapia, implantes intralesionais de 5 - fluorouracilo ou cisplatina, terapia fotodinâmica, anti-inflamatórios como o firocoxib, imunomoduladores como o imiquimode, eletroquimioterapia e retinoides (estes últimos em lesões pré-neoplásicas) também demonstraram ter efeitos benéficos. O prognóstico é favorável caso o diagnóstico seja feito precocemente. ABSTRACT - Cutaneous Squamous Cell Carcinoma in dogs - The Squamous Cell Carcinoma (SCC) is a neoplasia with {{origin in}} the keratinocytes and represents approximately 5 % of skin tumors in dogs. The cutaneous form of SCC presents mainly in areas of depigmented skin with little hair and affects animals of both sexes aged between 6 and 10 years. It is a locally invasive tumor but the occurrence of metastases is uncommon. Several etiological factors seem to lead to cutaneous SCC. However, ultraviolet radiation (UV) and papillomavirus (PV) are the most frequent ones. High altitude, lower latitude (tropical countries) and the ozone layer depletion {{increase the amount of}} UV rays that reach the earth's surface. The cutaneous injuries caused by UV radiation begin with dermatitis, that can progress to actinic keratosis (a pre-neoplastic injury) and this may evolve into SCC. UV radiation affects the p 53 tumor suppressor gene, leading to its mutation. The most frequent injury caused by solar radiation on the epidermal cells is the formation of thymine dimers between the DNA pyrimidine bases. In what regards PV, four of the seven types that have been described in dogs are associated with malignant transformation into SCC. They are: the canine oral Papillomavirus (COPV), Canis familiaris Papillomavirus type 2 (CfPV 2), canine Papillomavirus type 3 (CPV 3) and canine Papillomavirus type 4 (CPV 4). It is believed that the PV acts as cofactors of the injuries caused by solar radiation, blocking the apoptosis of the cells damaged by the UV rays. PV can also cause direct mutations in the p 53, inactivating it. The lesions of cutaneous SCC can manifest in two forms, the proliferative and the erosive one. The presumptive diagnosis is based on the medical history and physical examination, but the histopathological examination after biopsy is essential to reach a definitive diagnosis. Surgical excision with wide margins is the treatment that gets better long term results. Surgery combined with radiation therapy, 5 - fluorouracil and cisplatin intralesional implants, photodynamic therapy, anti-inflammatory drugs such as firocoxib, immunomodulators such as imiquimod, electrochemotherapy and retinoids (the latter in pre-neoplastic injuries) also demonstrated to have beneficial effects. The prognosis is favorable if the diagnosis is made in the early stages...|$|R
40|$|In {{the last}} years {{ammonium}} dinitramide (ADN) {{appeared to be a}} promising new oxidator and a possible substitute for ammonium nitrate (AN) and especially for the chlorinated oxidizer ammonium perchlorate. Among other main advantages of ADN are to be mentioned the higher energy input combined with a reduced pressure in application. Furthermore, <b>ADN</b> shows <b>no</b> phase transitions like AN. For evaluating the purity of the synthesized and/or treated or aged pure or formulated ADN, the estimated ammonium nitrate content was taken into account. AN is known to be as well a by-product of the ADN synthesis as a possible decomposition product of ADN. Thermally treated ADN decomposes mainly to N 2 O, H 2 O, NO 2 and AN which further reacts to N 2 O and NH 3. Determining the nitrate contents assuming the rest being intact ADN must not lead to correct values especially in cases where ADN was treated/handled at higher temperatures in open systems. Concerning the technical scale synthesis of ADN, the precursor ammonium nitrourethane (ANU) must be eliminated in a quick but sufficient way needing a suitable analysis method for detecting nitrourethane besides nitrate and ADN. The objective of this work was to develop a suitable ion chromatographic method for the direct analysis of the anions concerned. Different ion exchanger phases were tested with organic and/or inorganic eluants. The ionic strength and flow rate of the eluant was improved to get an acceptable resolution for nitrite and nitrate combined with a short run time for the whole analysis. Detection was realized by electrical conductivity or UV absorption whereby the measurement wavelengths were optimized {{in order to get a}} small signal-to-noise ratio and simultaneously a suitable sensitivity especially for NO 3 - and nitrourethane. Under improved conditions (Ion Pac 11, 1 ml/min NaOH, 300 mmol), limits of detection (LOD) of 0. 05 to 0. 01 ppm were realized for NO 3 - and NO 2 -, respectively, measured at 214 nm. Using 220 nm as detection wavelength resulted in a LOD of about 0. 3 ppm for nitrate. Using a wavelength between 210 and 220 nm results in a LOD for ANU of about 1 ppm. The linearity range for the analysis of DN- (285 nm) was found to be very broad (up to 700 ppm). All anions can be analyzed in one run taking maximally 30 minutes...|$|R
40|$|La congelación y almacenamiento en nitrógeno líquido (N 2 L) es la técnica más utilizada para preservar el semen de canino y de otras especies domésticas durante largos períodos de tiempo. Este estudio fue diseñado para validar el uso del ultracongelador de - 80 C para congelar y almacenar semen canino en pajuelas. Tres protocolos fueron ensayados (n= 10) : Control: semen congelado y almacenado en N 2 L; Exp. 1 : semen congelado y almacenado - 80 C, y Exp. 2 : semen congelado a - 80 C y almacenado en N 2 L. Postdescongelación se evaluó por citometría de flujo la viabilidad e integridad de membrana plasmática (SYBR- 14 /PI), potencial de membrana mitocondrial (DYm; JC- 1), integridad de la membrana del acrosoma (PSA/FITC­PI), translocación de fosfatidilserina (Annexin-V-FITC/PI) y fragmentación del <b>ADN</b> (TUNEL). <b>No</b> se observaron diferencias significativas (P The {{freezing}} and storage in liquid nitrogen (LN 2) is the technique used most {{for the preservation}} of canine and other domestic species semen, for long periods of time. This study was designed to validate the use of deep freezer at - 80 C to freeze and store canine semen in straws. Three protocols were tested (n = 10) : Control: sperm frozen in N 2 L and stored; Exp 1 : sperm frozen and stored - 80 °C, and Exp. 2 : semen frozen at - 80 ° C and stored in N 2 L. Post-thawing was assessed by flow cytometry and the viability of plasma membrane integrity (SYBR- 14 /PI), mitochondrial membrane potential (YDm, JC- 1), acrosome membrane integrity (PSA / FITC-PI), translocation of phosphatidylserine (Annexin -V-FITC/PI) and DNA fragmentation (TUNEL). No significant differences (P < 0. 05) between the Control, Exp. 2 and Exp. 1 groups regarding: intact plasma membrane integrity (42. 2 ± 5. 3, 35. 57 ± 10. 3 and 40. 76 ± 12. 1, respectively), YDm normal (54. 7 ± 20. 6, 44. 4 ± 15. 8 and 43. 4 ± 15. 3, respectively), intact acrosomal membrane integrity (42. 9 ± 11, 1, 53. 2 ± 15. 8 and 48. 7 ± 20. 1, respectively) and fragmented DNA (0. 87 ± 0. 41, 0. 75 ± 0. 16, 0. 79 ± 0. 27, respectively). However, the average motility of the post-thawing of Exp. 1 and Exp. 2 groups (37. 0 ± 4. 4 % 36. 8 ± 4. 1 % respectively) showed significant differences (P < 0. 05) than the Control group (55. 9 ± 8. 7 %). The results obtained in this study showed that the use of deep freezer at - 80 °C for {{freezing and}} storing canine sperm has potential use in veterinary medicine {{as an alternative to the}} use of N 2 L...|$|R
40|$|In normal {{epithelial}} cells, p 38 α has {{a well-established}} {{role as a}} tumor suppressor. However, recent reports have illustrated pro-tumorigenic functions for the p 38 α pathway by promoting tumor cell survival and proliferation. Given {{that the role of}} p 38 MAPKs {{have been shown to be}} cell and context dependent, we focused our study on the function of p 38 α in breast cancer progression. To investigate the role of p 38 α in breast tumor progression in vivo, we combined the polyoma middle T (PyMT) mouse model with floxed conditional alleles of p 38 α. This way, we analyzed the role of p 38 α in already developed tumors, where we observed a progressive tumor regression following p 38 α deletion (p 38 αΔ). This tumor reduction correlated with decreased cell proliferation, increased cell death and elevated levels of DNA damage. To investigate the molecular mechanisms underlying mammary tumor regression, we established epithelial cell cultures from PyMT-induced tumors. As increased levels of γ-H 2 AX were observed in tumors with reduced p 38 α, we examined DNA damage signaling and genome integrity in the PyMT-expressing epithelial cells. These cultures reproduced the increased levels of γ-H 2 AX observed in vivo and interestingly, the localization of γ-H 2 AX in these cells was not restricted to the nuclei, but also appeared in DNA bridges and micronuclei, potentially reflecting DNA double strand breaks resulting from chromosome segregation errors during cytokinesis. Increased levels of DNA damage are known to impact on DNA replication and hamper its progression. We directly assessed the effect of p 38 α deletion on DNA replication by analyzing stretched DNA fibers. We found a lower replication rate in p 38 αΔ cells and the analysis of fibers with bidirectional tracks revealed an increased rate of asymmetric forks, indicative of a high frequency of fork stalling. The defects in replication fork progression and the increased DNA damage led us to investigate the status of the DNA damage response, an essential network that monitors DNA replication and coordinates cellular responses. We observed defects in ssDNA generation, RPA accumulation, RPA and CHK 1 phosphorylation and RAD 51 recruitment after treatment with campothecin, a topoisomerase I inhibitor that induces DNA damage specifically in S-phase, indicating that ATR signaling, DNA-end resection and homologous recombination DNA repair were defective in p 38 α deficient cells. Moreover, we identified CtIP, a key factor that promotes DNA-end resection in mammalian cells, as a p 38 α substrate. De-regulation of CtIP due to lack of p 38 α could impact on the DNA damage response and explain many of the described phenotypes. Replication stress and DNA damage have been proposed to be the major cause of chromosome instability (CIN) in cancer, leading to both numerical and structural chromosome alterations. Using time- lapse analysis, we observed that some cells showed cytokinesis failure, reflected by the presence of DNA bridges between the daughter cells, and gave rise to multinucleated cells. However, even in the presence of DNA bridges, most of the p 38 αΔ cells were able to eventually divide, but exhibited micronuclei after mitosis. This indicated that p 38 α deletion induced missegregation, ultimately leading to aneuploidy. Our results suggested that targeting p 38 α would increase tumor cell sensitivity to CIN-inducing agents. We tested this hypothesis both in vitro and in vivo, and found that pharmacological inhibition of p 38 α increased the effect of both paclitaxel and docetaxel in the PyMT model. These results were further confirmed in patient-derived xenografts, where p 38 α inhibition enhanced, accelerated or prolonged the anti-tumoral response observed with the taxanes alone. These results were consistent with the idea that p 38 α contributes to the DNA damage response and facilitates the survival of cancer cells with high levels of CIN. Moreover, they confirmed the hypothesis that targeting p 38 α sensitizes cancer cells to CIN-inducing agents such as taxanes, raising the possibility of translating p 38 α inhibitors into the clinic. La proteína quinasa p 38 α está considerada como un supresor tumoral. Sin embargo, estudios recientes sugieren que puede promover el crecimiento y la supervivencia en algunos tipos de células tumorales, así como que su inhibición coopera con determinados agentes quimioterapéuticos. Así pues, la función de p 38 α parece depender tanto del tipo de célula como del contexto. Por ello, este trabajo abordó el papel de p 38 α en el contexto concreto de la progresión del cáncer de mama. Usando el modelo “Polyoma middle T” (PyMT), hemos observado que la expresión de p 38 α en las células epiteliales que conforman el tumor es esencial para el crecimiento del mismo. Para analizar los mecanismos moleculares implicados establecimos un sistema ex vivo consistente en líneas celulares derivadas de tumores inducidos por PyMT. Observamos que en ausencia de p 38 α estas células mostraban estrés replicativo, un mayor daño en el ADN y un incremento en los errores de segregación que correlacionaban con una menor viabilidad celular. Los defectos durante la replicación y el aumento en el daño en el <b>ADN</b> <b>nos</b> llevaron a investigar el estado de la ruta de respuesta al daño en el ADN. Así pues, encontramos que las células deficientes en p 38 α mostraban defectos en la generación de ADN monocatenario, en la activación de ATR y en el reclutamiento de RAD 51 a los focos de daño, lo que sugería que la reparación de ADN por recombinación homóloga estaba afectada. Además identificamos CtIP, un factor esencial para la resección del ADN, como sustrato directo de p 38 α. La desregulación de CtIP influiría negativamente en la respuesta al daño en el ADN y explicaría en gran medida los fenotipos descritos anteriormente. En conjunto, nuestros datos sugieren que p 38 α es necesaria para una eficiente reparación y replicación del ADN y por tanto para el mantenimiento de la estabilidad cromosómica en las células epiteliales de cáncer de mama. Los resultados anteriores sugerían que la intervención farmacológica de p 38 α podría incrementar la sensibilidad a agentes inductores de inestabilidad cromosómica como los taxanos. Confirmamos esta teoría usando el modelo PyMT y xenografías derivadas de pacientes, comprobando que en ambos casos la inhibición de p 38 α potenció, aceleró o prolongó el efecto anti-tumoral de los taxanos paclitaxel y docetaxel...|$|R
40|$|ES] LAS RUTAS AGRUPADAS BAJO EL NOMBRE DE TOLERANCIA AL DAÑO, CONSTITUYEN UNO DE LOS MECANISMOS ENCARGADOS DE ASEGURAR LA SUPERVIVENCIA CELULAR, UNA VEZ SE VEA COMPROMETIDA LA INTEGRIDAD DEL GENOMA. A TRAVÉS DE LAS DOS VARIANTES EXISTENTES DENTRO DE LA TOLERANCIA AL DAÑO, LAS RUTAS ¿ERROR FREE¿ Y ¿ERROR PRONE¿, LA CÉLULA SERÁ CAPAZ DE REPLICAR LOS SITIOS DE <b>ADN</b> DAÑADOS QUE <b>NO</b> PUDIERON SER REPARADOS ANTES DEL INICIO DE LA REPLICACIÓN. LA ACTIVACIÓN DE DICHAS RUTAS CELULARES EN TODOS LOS ORGANISMOS MODELO ESTUDIADOS HASTA LA FECHA, VIENE DADA POR LA UBIQUITINACIÓN DE PCNA (DEL INGLÉS PROLIFERATING CELL NUCLEAR ANTIGEN) A TRAVÉS DE UN COMPLEJO UBIQUITINA LIGASA E 2 -E 3. A PESAR DE QUE LAS PROTEÍNAS IMPLICADAS EN REALIZAR ESTA MODIFICACIÓN DE UBIQUITINACIÓN, ESTÁN MUY BIEN CARACTERIZADAS EN TODOS LOS EUCARIOTAS, MUY POCO SE SABE DE LAS PROTEÍNAS ENCARGADAS DE REVERTIR DICHO PROCESO DE UBIQUITINACIÓN, DESACTIVANDO ASÍ LAS RUTAS DE TOLERANCIA AL DAÑO. IDENTIFICAR A LA, O A LAS PROTEÍNAS RESPONSABLES DE HACERLO EN LA LEVADURA DE FISIÓN Schizosaccharomyces pombe, HA CONSTITUIDO EL OBJETIVO PRINCIPAL DE ESTA TESIS DOCTORAL. PARA LLEVAR A CABO NUESTRO ESTUDIO, SE CONSTRUYERON CEPAS MUTADAS PARA CADA UNA DE LAS PROTEASAS DE UBIQUITINA DESCRITAS EN S. pombe. LOS ANÁLISIS GENÉTICOS Y BIOQUÍMICOS REALIZADOS CON DICHAS CEPAS, DEMOSTRARON QUE LAS DESUBIQUITINASAS PERTENECIENTES A LA FAMILIA USP/UBP: UBP 16, UBP 15 Y UBP 12; SON LAS PROTEASAS ENCARGADAS DE DESUBIQUITINAR A PCNA EN LA LEVADURA DE FISIÓN. ADEMÁS, ANÁLISIS DE SENSIBILIDAD A DIFERENTES AGENTES GENOTÓXICOS DE LAS CEPAS SOBRE-EXPRESORAS DE CADA UNA DE LAS UBPS MENCIONADAS, PUSIERON DE MANIFIESTO, QUE UBP 16 ES LA PROTEASA QUE SOPORTA EL PAPEL PRINCIPAL EN LA DESUBIQUITINACIÓN DE PCNA. [EN] ROUTES GROUPED UNDER THE NAME OF DAMAGE TOLERANCE, ARE ONE OF THE MECHANISMS RESPONSIBLE FOR ENSURING SURVIVAL CELL ONCE {{compromised}} genome integrity. THROUGH THE TWO VERSIONS WITHIN THE EXISTING DAMAGE TOLERANCE, ROUTE ERROR FREE ? And ERROR PRONE ? ¿ CELL BE ABLE TO REPLICATE THE SITES THAT COULD BE DAMAGED DNA UNREPAIRED BEFORE THE START OF THE REPLICATION. CELLULAR ACTIVATION SUCH ROUTES IN ALL MODEL AGENCIES STUDIED TO DATE, {{is given}} by the ubiquitination of PCNA (proliferating ENGLISH CELL NUCLEAR ANTIGEN) THROUGH A COMPLEX UBIQUITIN LIGASE E 2 -E 3. ALTHOUGH THE IMPLIED PROTEIN ubiquitination PERFORM THIS MODIFICATION ARE VERY WELL CHARACTERIZED in all eukaryotes, LITTLE KNOWN PROTEIN RESPONSIBLE FOR SUCH PROCESS OF REVERSE ubiquitination, thereby disabling ROUTES OF DAMAGE TOLERANCE. IDENTIFY THE OA PROTEIN RESPONSIBLE TO DO IN FISSION YEAST Schizosaccharomyces pombe, HAS ESTABLISHED THE MAIN OBJECTIVE OF THIS THESIS. TO COMPLETE OUR SURVEY, SE mutated strains BUILT FOR EACH OF THE PROTEASE UBIQUITIN DESCRIBED IN S. pombe. BIOCHEMICAL GENETIC ANALYSIS AND MADE SUCH STRAINS, SHOWED THAT THE FAMILY BELONGING DESUBIQUITINASAS USP / UBP : UBP 16, UBP 15 and UBP 12; ARE RESPONSIBLE FOR PROTEASE DESUBIQUITINAR PCNA IN A FISSION YEAST. FURTHER ANALYSIS OF SENSITIVITY TO DIFFERENT STRAINS ON genotoxic - expressor OF EACH OF THE ABOVE UBPS, revealed, THAT IS THE PROTEASE UBP 16 AGENTS THAT SUPPORTS THE MAIN ROLE IN deubiquitination of PCNA...|$|R
40|$|As bases nucleotÃdicas guanina (G), adenina (A), citosina (C) e timina (T) sÃo bases nucleotÃdicasos blocos essenciais da molÃcula do Ãcido desoxiribonucleico (ADN), que contÃm a as informaÃÃes genÃticas usadas pelas cÃlulas vivas. Filamentos de ADN sÃo tambÃm candidatos promissores para fabricaÃÃo nanodispositivos moleculares, visto que polÃmeros estÃveis e de fÃcil replicaÃÃo. Apesar desta sugestÃo inicial da possibilidade de usar o ADN como condutor em nanoescala apenas dez anos apÃs a elucidaÃÃo da estrutura {{helicoidal}} do ADN, o transporte de portadores de cargas atravÃs de estruturas baseadas <b>no</b> <b>ADN</b> ainda sÃo matÃria de debate. Aqui, sÃo apresentadas as propriedades estruturais, eletrÃnicas e Ãpticas dos cristais anidros das bases do ADN obtidas apÃs cÃlculos baseados na teoria do funcional da densidade (DFT, do inglÃs Density Functional Theory), assim como medidas de absorÃÃo Ãtica para o pÃ desses cristais. Os experimentos do espectro absorÃÃo UV para os cristais foram realizadas sobre pastilhas usando o espectrometro Varian Cary 5000 UV-visible NIR, considerando o intervalo de 200 and 800 nm (50000 - 12500 cm- 1). Os cÃlculos teÃricos da presente tese foram desenvolvidos usando o pacote CASTEP, baseado na teoria DFT. Na descriÃÃo do potencial de troca e correlaÃÃo, foi utilizada aproximaÃÃo {{local da}} densidade (LDA, do inglÃs Local Density Approximation) desenvolvida por Cerpeley e Alder e parametrizado por Perdew e Zunger (CA-PZ). Sobre a escolha do funcional, uma observaÃÃo deve ser feita: nos cristais anidros das bases do ADN, interaÃÃes de van der Waals ao longo do eixo de empilhamento molecular e as ligaÃÃes de hidrogÃnio entre as molÃculas do mesmo plano sÃo relevantes na explicaÃÃo das suas caracterÃsticas, e Ã bem conhecido que os mÃtodos de DFT puro sÃo incapazes de uma boa descriÃÃo das forÃas dispersivas. AlÃm disso, a aproximaÃÃo LDA nÃo Ã a melhor opÃÃo para cÃlculos precisos das ligaÃÃes de hidrogÃnio. Entretanto, alguns trabalhos DFT de cristais formados por camadas tais como grafite e o cristal hidratado da guanina mostraram que o funcional LDA fornece valores razoÃveis para as distÃncias atÃmicas, contrariando as limitaÃÃes desse funcional. Isso e o baixo custo computacional foram as motivaÃÃes que levaram a sua escolha em vez da adoÃÃo de funcionais mais sofisticados (e computacionalmente mais pesados). Os cristais de guanina e citosina (adenina e timina) sÃo previstos terem gaps diretos (indiretos), com os valores experimentais estimados a partir da absorÃÃo de 3, 7 eV e 3, 8 eV (3, 8 eV e 4, 0 eV), na mesma ordem. Os resultados LDA mostraram gaps de energia menores do que os valores experimentais, como esperado, e os gaps experimentais estimados a partir da absorÃÃo Ãtica sÃo, em geral, menores do que os valores experimentais disponÃveis na literatura (exceto, para a guanina). A ordem crescente nos valores calculados dos gaps de energia para os cristais Ã dada por G < A < C < T, enquanto os valores experimentais obtidos nesta tese (a partir da absorÃÃo Ãptica) seguem a ordem A < G < C < T em contraste com as medidas de raios-x, que indicam a sequÃncia G < C < A < T. Para os elÃtrons e buracos se movendo das ligaÃÃes de hidrogÃnio (paralelas ao plano molecular da base), as massas efetivas sÃo geralmente elevadas, exceto para a timina. Quando os mesmos elÃtrons se movimentam ao do eixo de empilhamento molecular, entretanto, as massas efetivas ficam entre 4, 0 e 6, 3 m 0, sugerindo estes cristais se comportam como semicondutores de gap largo ao longo das direÃÃes de empilhamento molecular. O transporte de buracos tambÃm Ã favorecido ao longo da direÃÃo de empilhamento, exceto para a timina. Finalmente, a funÃÃo dielÃtrica complexa foi calculada para cada cristal anidro das bases do ADN, sendo observada uma forte anisotropia para a incidÃncia de luz polarizada nos casos da guanina, adenina e timina, mas nÃo para a citosina. Guanine (G), adenine (A), cytosine (C), and thymine (T) nucleotide bases are the essential {{building blocks of}} DNA (deoxyribonucleic acid), which contains the genetic information used to build living cells. DNA strands are also promising candidates to fabricate molecular nanodevices, since they are stable polymers easy to replicate. Despite the early suggestion {{of the possibility of}} using DNA as a nanoscale conductor almost ten years after the elucidation of its helical structure, charge carrier transport through DNA-based structures is still a matter of debate. Here, we present the structural, electronic and optical properties of anhydrous crystals of DNA nucleobases found after DFT (Density Functional Theory) calculations, as well as experimental measurements of optical absorption for powders of these crystals. Experimental measurements of the UV absorption spectra for the anhydrous crystals were carried out on these pellets using a Varian Cary 5000 UV-visible NIR spectrophotometer. The absorption spectrum of the samples was recorded in the wavelength range between 200 and 800 nm (50000 - 12500 cm- 1). The computational simulations of the present work were performed using the CASTEP code, which is based in the DFT approach. The Local Density Approximation (LDA) exchange-correlation potential developed by Ceperley and Alder and parametrized by Perdew and Zunger was adopted as well. With respect to our choice of functional, a note of caution must be made: in anhydrous DNA bases crystals, van der Waals interactions along the molecular stacking axis and hydrogen bonding between molecules in the same stacking plane are relevant to explain their structural features, and {{it is well known that}} pure DFT methods are unable to give a good description of dispersive forces. Besides, the LDA approximation is not the best option to provide an accurate account of hydrogen bonds. However, some DFT studies of layered crystals such as graphite as well as guanine hydrated crystals have shown that the LDA gives reasonable values for atomic distances, notwithstanding the limitations of this functional. This and the relatively low cost of LDA computations have motivated us to its adoption instead of more sophisticated (and computationally expensive) means. Guanine and cytosine (adenine and thymine) anhydrous crystals are predicted from the DFT simulations to be direct (indirect) band gap semiconductors, with values 2. 68 eV and 3. 30 eV (2. 83 eV and 3. 32 eV), respectively, while the experimentally estimated band gaps we have measured are 3. 7 eV and 3. 8 eV (3. 5 eV and 4. 0 eV), in the same order. Our LDA figures for the energy gaps are smaller than experimental values, as expected, and the gaps estimated from the optical absorption measurements presented in this work are in general smaller than experimental data available in the literature (except for guanine). The LDA ordering of increasing band gaps is G < A < C < T, while the ordering of gaps obtained experimentally is not settled: our work finds (from optical absorption measurements) A < G < C < T in contrast with the X-ray measurements, that indicate the energy gap sequence G < C < A < T. For electrons and holes moving along selected hydrogen bonds (parallel to the molecular plane of a given nucleobase), effective masses are in general large, exception made to thymine. When the same electrons move along the pi-stacking axis, however, effective masses stay between 4. 0 and 6. 3 free electron masses (m 0), which suggests that stackings of nucleobases behave like wide gap semiconductors for electrons. The perpendicular transport of holes is also favored for nucleobase stackings without thymine. Finally, the complex dielectric function was calculated for each anydrous DNA base crystal, and a very pronounced anisotropy was observed for polarized incident light in the cases of guanine, adenine, and thymine, but not for cytosine...|$|R
40|$|Glioblastoma multiforme (GBM) {{is by far}} {{the most}} common {{malignant}} subtype of glial tumors. Despite implementation of intensive therapeutic strategies and supportive care, the disease invariably leads to death over a short period of time after diagnosis. Despite the inter- and intratumoral heterogeneity of these tumors at the histopathological, genomic and transcriptional levels, at present it is still not possible to identify already at diagnosis, which patients will benefit from different treatment strategies. In turn, the pathogenesis of glioblastoma is still far from being completely understood. Overall, GBM is considered to be a multifactorial disorder, which arises from complex interactions between a variety of genetic and epigenetic alterations, environmental exposure and genetic susceptibility. Accumulative DNA damage responsible for tumor transformation is believed to be due to a multistep process that involves functional inactivation of tumor suppressor genes and DNA repair genes, and/or activation of oncogenes. Multiple studies aimed at identifying genetic alterations in GBM which are involved in tumor development and progression, have been reported in the past. Commonly observed genetic alterations include amplification and/or mutation of the epidermal growth factor receptor (EGFR), the cyclin-dependent kinase 4 (CDK 4) gene, and the mouse double-minute 2 (MDM 2) genes, among other genes; in turn, deletion/mutation of tumor suppressor genes, such as the tumor protein p 53 (TP 53) gene, the phosphatase and tensin homolog (PTEN) and the cyclin-dependent kinase inhibitor 2 A (CDKN 2 A/p 16) genes, has also been frequently reported in these tumors. On top of this, a variety of multiple other numeric chromosomal alterations have been described in glioblastomas; among other, these include trisomy of chromosome 7 and gains of chromosomes 12 p, 19 q, and 20 q, together with deletion of chromosomes 1, 9, 10, and 19. Based on their biological and genetic features, two different subgroups of GBM tumors have been defined which have a distinct ontogeny: the vast majority of GBM present as primary tumors or de novo glioblastomas in older patients without evidence for a less malignant precursor lesion, whereas secondary glioblastoma, slowly progressing from a low-grade glioma in younger patients, is infrequent. EGFR amplification and/or EGFR mutation, deletion of PTEN and p 16 are recurrent events in 3 primary glioblastomas, whereas TP 53 and IDH 1 /IDH 2 mutations are early and frequent genetic alterations in the pathway leading to secondary GBM. Despite important progress has been made in our understanding of the molecular pathogenesis of primary glioblastoma, no definitive genetic signature exists for this brain neoplasm, and no tumor-specific genetic marker with indubitable prognostic value is currently available. Taken together, these evidences reinforce the need to better understand the mechanisms by which genetic and molecular alterations occur in GBM, as well as their impact on the clinical and biological behavior of the tumor. Recent availability of new highly sensitive high-throughput approaches, such as those based on microarray technology, facilitates the identification of genetic/chromosomal abnormalities occurring in GBM, at the same time they may also contribute to the discovery of new and smaller alterations, which might have not yet been associated with the pathogenesis of the tumor. In the present study, we performed whole-genome DNA analysis using both high-density single nucleotide polymorphism (SNP) -arrays, and massive mRNA analyses of human GBM tumor samples. Our goal focused on the identification of those genes amplified or deleted in primary glioblastoma, and their relationship with specific genetic and gene expression profiles, as well as with disease outcome. In a first step, a group of 35 primary glioblastomas were screened for specific DNA copy number (CN) alterations involving chromosomal regions of gain and loss of gene sequences, using SNP-arrays. At this point, special attention was paid to those genetic alterations of chromosomes 7, 9 p and 10 q, which were present in virtually every case (97 %, 83 % and 91 % of the cases, respectively). Interphase fluorescence in situ hybridization (iFISH) studies performed in parallel confirmed the high frequency of these alterations as detected by SNP-arrays. Once the alterations detected for these three chromosomes were simultaneously considered, five distinct cytogenetic profiles emerged, which identified distinct prognostic subgroups of glioblastomas. Of note, those tumors displaying EGFR amplification clearly showed a better outcome among older (> 60 years old) patients, as confirmed by further multivariate analysis of a larger series (n= 119) of primary GBM from public databases. In addition, we determined the precise extension of those critical DNA sequences affected by CN alterations involving chromosomes 7, 9 and 10, and identified the specific genes they contained; such genes 4 are likely to be involved in the pathogenesis and/or malignant transformation of glioblastoma. In the second part of the study, we extended our previous analysis to a total of 46 GBM. Now, we used SNP-arrays to investigate recurrent CN alterations (e. g. amplification and deletions) for all human chromosomes, to identify those genes specifically involved in such alterations, and evaluated the impact of said alterations on the mRNA levels of the involved genes. Overall, recurrent amplicons were detected for chromosomes 7 (50 %), 12 (22 %), 1 (11 %), 4 (9 %), 11 (4 %), and 17 (4 %), while recurrent homozygous deletions involved chromosomes 9 p 21 (52 %) and 10 q (22 %). Interestingly, most genes which displayed a high correlation between DNA CN values and mRNA levels were coded in the amplified chromosomal regions; by contrast, for the homozygously deleted regions, such correlation was restricted to the methylthioadenosine phosphorylase (MTAP) gene coded at chromosome 9 p 21. These findings strengthen the presence of novel candidate oncogenes and tumor suppressor genes mapping to regions of amplicons and of chromosome deletion, respectively. In summary, here we show that the combination of high-throughput genomic and transcriptional data is crucial to define recurrent cytogenetic profiles in GBM and differentiate between those genes that show concordant CN alterations and expression patterns and that consequently may have functional relevance in the pathogenesis of glioblastoma, and genes whose alteration does not translate into a different gene expression profile (GEP). Such comprehensive analysis also allowed the identification of new candidate genes as preferential targets for amplification in GBM. Further studies in larger series of patients are required to confirm the potential clinical significance of our findings. O glioblastoma multiforme (GBM) é o subtipo maligno mais comum de todos os tumores gliais. Apesar da implementação de estratégias terapêuticas intensivas, a doença conduz invariavelmente à morte, num curto período de tempo após o diagnóstico. Apesar da heterogeneidade inter e intratumoral destes tumores a nível histopatológico, genómico e transcripcional, ainda não é possível identificar no momento do diagnóstico, que doentes beneficiarão das diferentes estratégias terapêuticas. Por sua vez, a patogénese destes tumores está longe de ser completamente esclarecida. O GBM é considerado uma doença multifactorial, que surge a partir de interações complexas entre uma variedade de alterações genéticas e epigenéticas, a exposição ambiental e a susceptibilidade genética. Danos cumulativos <b>no</b> <b>ADN,</b> responsáveis pela transformação do tumor, são devidos a um processo sequencial que envolve a inactivação funcional de genes supressores tumorais e de genes de reparação do ADN e/ou a activação de oncogenes. Diversos estudos anteriores focaram a sua investigação na identificação de alterações genéticas que pudessem estar envolvidas no desenvolvimento e progressão do GBM. Alterações frequentes incluem a amplificação e/ou mutação dos genes EGFR, CDK 4 e MDM 2, entre outros genes; por sua vez, a deleção/mutação de genes supressores tumorais, tais como os genes TP 53, PTEN e CDKN 2 A/p 16, são também recorrentes nestes tumores. Múltiplas alterações cromossómicas numéricas foram igualmente descritas em glioblastomas, incluindo entre outras, trissomia do cromossoma 7, ganhos dos cromossomas 12 p, 19 q, 20 q e perdas dos cromossomas 1, 9, 10, e 19. Com base nas características biológicas e genéticas destes tumores, definem-se dois subgrupos de GBM, com diferente ontogenias: a grande maioria dos GBM apresenta-se como tumores primários ou “de novo” em doentes de uma faixa etária superior, sem evidência de uma lesão precursora de menor grau de malignidade, enquanto os GBM secundários são pouco frequentes e progridem lentamente a partir de um glioma de baixo grau, sendo mais comuns em doentes jovens. A amplificação e/ou mutação do gene EGFR e a perda dos genes PTEN e p 16 são eventos recorrentes em GBM primários, enquanto as mutações dos genes TP 53 e 7 IDH 1 /IDH 2 são alterações genéticas iniciais na progressão para o glioblastoma secundário. Apesar dos progressos no conhecimento sobre a patogénese molecular dos GBM primários, não existe uma assinatura genética definitiva para esta neoplasia cerebral e, actualmente, não existe também nenhum marcador tumoral específico com valor prognóstico claro. Estas evidências reforçam a necessidade de compreender melhor os mecanismos pelos quais as alterações genéticas e moleculares ocorrem no GBM, bem como o seu impacto sobre o comportamento clínico e biológico do tumor. A recente disponibilidade de novas abordagens de grande sensibilidade, resolução e rendimento, tais como a tecnologia de “microarrays”, facilita a identificação de alterações genéticas/cromossómicas que ocorrem nos glioblastomas e, ao mesmo tempo, poderão contribuir para a descoberta de novas alterações que não tenham sido ainda associadas à patogénese do tumor. No presente estudo, procedemos à análise do ADN tumoral utilizando a tec ologia de “SNP-arrays” e à análise massiva do RNAm de amostras tumorais de glioblastomas humanos. O nosso objetivo centrou-se na identificação de genes amplificados ou perdidos no glioblastoma primário, e a sua relação com determinados perfis genéticos e de expressão génica, bem como com a evolução da doença. Na primeira parte deste estudo, realizámos a pesquisa de alterações específicas no número de cópias do ADN, envolvendo regiões cromossómicas de ganho e de perda de sequências genéticas, aplicando a tec ologia de “SNP-arrays” no estudo de 35 glioblastomas primários. Prestámos especial atenção às alterações genéticas observadas nos cromossomas 7, 9 p e 10 q, presentes em praticamente todos os casos analisados (97 %, 83 % e 91 % dos casos, respectivamente). Os estudos de hibridização in situ fluorescente em núcleos interfásicos (iFISH) realizados em paralelo confirmaram a elevada frequência destas alterações genéticas, anteriormente detectadas por “SNParrays”. Considerando simultaneamente as alterações observadas nestes três cromossomas, identificámos cinco perfis citogenéticos distintos, que reflectiam distintos subgrupos de glioblastomas com um prognóstico diferente. Em particular, os tumores com amplificação de gene EGFR apresentaram claramente um prognóstico mais favorável em doentes com mais de 60 anos, como confirmado pela análise multivariada de uma série maior (n= 119) de glioblastomas primários, disponível em 8 9 bases de dados públicas. Determinámos ainda a extensão exacta das sequências de ADN afectadas por alterações do número de cópias dos cromossomas 7, 9 e 10, e identificámos os genes específicos aí contidos, susceptíveis de estar envolvidos na patogénese e/ou transformação maligna do glioblastoma. Na segunda parte do estudo, alargámos a análise anterior a um total de 46 glioblastomas. c t c g d “SNP-arrays” para investigar alterações recorrentes no número de cópias (ex., amplificação e delecção) em todos os cromossomas do genoma, com o objectivo de identificar os genes especificamente envolvidos nestas alterações; posteriormente, avaliámos o impacto das referidas alterações nos níveis de RNAm dos genes implicados. Em geral, as amplificações detectadas com maior frequência foram aquelas que afectaram os cromossomas 7 (50 %), 12 (22 %), 1 (11 %), 4 (9 %), 11 (4 %) e 17 (4 %), enquanto as delecções recorrentes envolveram os cromossomas 9 p 21 (52 %) e 10 q (22 %). Curiosamente, a maioria dos genes que apresentaram uma elevada correlação entre o número de cópias de ADN e os níveis de RNAm, estavam codificados nas regiões cromossómicas amplificadas; pelo contrário, para as regiões de delecção homozigótica, tal correlação foi restrita ao gene MTAP, codificado no cromossoma 9 p 21. Estes resultados reforçam a noção da possível presença de novos oncogenes e genes supressores tumorais candidatos, localizados nas regiões de amplificação e delecção cromossómica, respectivamente. Em resumo, neste estudo demonstrámos que a combinação dos resultados obtidos ao nível genómico e transcripcional é essencial para definir perfis citogenéticos recorrentes no glioblastoma, permitindo diferenciar os genes com alterações concordantes entre o número de cópias e os padrões de expressão, podendo assim ter relevância funcional na patogénese do glioblastoma, dos genes cuja alteração não se traduz num perfil de expressão génica distinto. Esta análise abrangente, permitiu ainda a identificação de novos genes, candidatos a alvos preferenciais para a ocorrência de amplificação genética nos GBM. Estudos adicionais em séries mais alargadas serão necessários para confirmar o potencial significado clínico dos nossos resultados...|$|R

